Net profit of Sudarshan Pharma Industries declined 28.91% to Rs 4.18 crore in the quarter ended September 2025 as against Rs 5.88 crore during the previous quarter ended September 2024. Sales rose 31.33% to Rs 168.87 crore in the quarter ended September 2025 as against Rs 128.58 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales168.87128.58 31 OPM %5.4510.15 - PBDT5.139.67 -47 PBT4.239.00 -53 NP4.185.88 -29 Powered by Capital Market - Live News

Sudarshan Pharma Industries will hold a meeting of the Board of Directors of the Company on 18 October 2025.Powered by Capital Market - Live News

Net profit of Sudarshan Pharma Industries reported to Rs 3.96 crore in the quarter ended June 2025 as against net loss of Rs 1.21 crore during the previous quarter ended June 2024. Sales rose 46.43% to Rs 145.26 crore in the quarter ended June 2025 as against Rs 99.20 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales145.2699.20 46 OPM %7.602.10 - PBDT6.29-0.88 LP PBT5.41-1.55 LP NP3.96-1.21 LP Powered by Capital Market - Live News

Sudarshan Pharma Industries will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live News

Sudarshan Pharma Industries announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 August 2025.Powered by Capital Market - Live News